Denosumab
Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion

Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion

The US Food and Drug Administration (FDA) has mandated “black box” warnings on six major CAR-T cancer therapies ove...

Impressions : 2736

Headwinds at Mylan; Chinese API Adulteration Concerns Trigger Another US Drug Recall

This week in Phispers, we look at Mylan’s US operations that declined 22 percent due to lower volumes. Moreover, quality ...

Impressions : 6937